Lam Research (LRCX) Stock Forecast, Price Target & Predictions
LRCX Stock Forecast
Lam Research stock forecast is as follows: an average price target of $827.05 (represents a 9.38% upside from LRCX’s last price of $756.12) and a rating consensus of 'Buy', based on 17 wall street analysts offering a 1-year stock forecast.
LRCX Price Target
The average price target for Lam Research (LRCX) is $827.05 based on 1-year price targets from 17 Wall Street analysts in the past 3 months, with a price target range of $1.13K to $543.00. This represents a potential 9.38% upside from LRCX's last price of $756.12.
LRCX Analyst Ratings
According to 17 Wall Street analysts, Lam Research's rating consensus is 'Buy'. The analyst rating breakdown for LRCX stock is 0 'Strong Buy' (0.00%), 10 'Buy' (58.82%), 7 'Hold' (41.18%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Lam Research Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 05, 2024 | Tom O'Malley | Barclays | $900.00 | $922.73 | -2.46% | 19.03% |
| May 22, 2024 | Joseph Quatrochi | Wells Fargo | $980.00 | $964.00 | 1.66% | 29.61% |
| Apr 25, 2024 | Charles Shi | Needham | $950.00 | $898.24 | 5.76% | 25.64% |
| Apr 25, 2024 | Craig Ellis | B.Riley Financial | $1.13K | $884.89 | 27.70% | 49.45% |
| Apr 25, 2024 | Mehdi Hosseini | Susquehanna | $850.00 | $884.89 | -3.94% | 12.42% |
| Apr 25, 2024 | Vijay Rakesh | Mizuho Securities | $960.00 | $884.89 | 8.49% | 26.96% |
| Apr 25, 2024 | Tom O'Malley | Barclays | $865.00 | $884.89 | -2.25% | 14.40% |
| Apr 19, 2024 | Craig Ellis | B.Riley Financial | $1.10K | $888.92 | 23.75% | 45.48% |
| Apr 18, 2024 | Quinn Bolton | Needham | $1.03K | $896.08 | 14.95% | 36.22% |
| Apr 16, 2024 | Brian Chin | Stifel Nicolaus | $1.05K | $963.23 | 9.01% | 38.87% |
The latest Lam Research stock forecast, released on Jun 05, 2024 by Tom O'Malley from Barclays, set a price target of $900.00, which represents a -2.46% decrease from the stock price at the time of the forecast ($922.73), and a 19.03% increase from LRCX last price ($756.12).
Lam Research Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 14 |
| Avg Price Target | - | - | $954.29 |
| Last Closing Price | $756.12 | $756.12 | $756.12 |
| Upside/Downside | -100.00% | -100.00% | 26.21% |
In the current month, the average price target of Lam Research stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Lam Research's last price of $756.12. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 01, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jun 20, 2024 | B. Riley | Buy | Buy | Hold |
| Jun 07, 2024 | Raymond James | Outperform | Outperform | Hold |
| Jun 05, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| May 22, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 21, 2024 | Citigroup | Buy | Buy | Hold |
| May 21, 2024 | Deutsche Bank | Hold | Hold | Hold |
| May 13, 2024 | UBS | Underperform | Underperform | Hold |
| May 13, 2024 | Wells Fargo | Buy | Buy | Hold |
| Apr 25, 2024 | KeyBanc | Sector Weight | Sector Weight | Hold |
Lam Research's last stock rating was published by Cowen & Co. on Aug 01, 2024. The company gave LRCX a "Buy" rating, the same as its previous rate.
Lam Research Financial Forecast
Lam Research Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.76B | $3.48B | $3.21B | $3.87B | $5.28B | $5.07B | $4.64B | $4.06B | $4.23B | $4.30B | $4.15B | $3.85B | $3.46B | $3.18B |
| Avg Forecast | $5.60B | $5.53B | $5.35B | $5.75B | $6.20B | $6.10B | $5.47B | $5.29B | $5.18B | $4.96B | $4.70B | $4.44B | $4.26B | $4.05B | $3.82B | $3.72B | $3.71B | $3.42B | $3.13B | $3.82B | $5.10B | $4.92B | $4.21B | $4.25B | $4.41B | $4.32B | $4.03B | $3.72B | $3.34B | $3.11B |
| High Forecast | $5.67B | $5.59B | $5.42B | $5.82B | $6.28B | $6.18B | $5.54B | $5.36B | $5.24B | $5.02B | $4.76B | $4.50B | $4.31B | $4.11B | $3.87B | $3.77B | $3.75B | $3.47B | $3.17B | $3.86B | $5.16B | $4.98B | $4.24B | $4.27B | $4.44B | $4.35B | $4.06B | $3.75B | $3.36B | $3.13B |
| Low Forecast | $5.49B | $5.42B | $5.25B | $5.64B | $6.08B | $5.99B | $5.37B | $5.19B | $5.08B | $4.86B | $4.61B | $4.36B | $4.18B | $3.98B | $3.75B | $3.65B | $3.70B | $3.36B | $3.07B | $3.74B | $5.00B | $4.83B | $4.17B | $4.21B | $4.37B | $4.28B | $3.99B | $3.69B | $3.31B | $3.08B |
| # Analysts | 13 | 7 | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 6 | 7 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.02% | 1.01% | 1.03% | 1.03% | 1.10% | 0.96% | 0.96% | 1.00% | 1.03% | 1.03% | 1.04% | 1.02% |
Lam Research's average Quarter revenue forecast for Mar 24 based on 6 analysts is $3.72B, with a low forecast of $3.65B, and a high forecast of $3.77B. LRCX's average Quarter revenue forecast represents a -0.97% decrease compared to the company's last Quarter revenue of $3.76B (Dec 23).
Lam Research EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 13 | 7 | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 6 | 7 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.06B | $1.02B | $947.69M | $1.11B | $1.77B | $1.77B | $1.57B | $1.28B | $1.48B | $1.47B | $1.44B | $1.29B | $1.11B | $1.05B |
| Avg Forecast | $1.78B | $1.76B | $1.70B | $1.83B | $1.97B | $1.94B | $1.74B | $1.68B | $1.65B | $1.58B | $1.49B | $1.41B | $1.35B | $1.29B | $1.22B | $1.55B | $1.18B | $1.09B | $995.75M | $1.41B | $1.62B | $1.59B | $1.34B | $1.28B | $1.40B | $1.38B | $1.28B | $1.12B | $1.06B | $988.81M |
| High Forecast | $1.80B | $1.78B | $1.72B | $1.85B | $2.00B | $1.97B | $1.76B | $1.71B | $1.67B | $1.60B | $1.51B | $1.43B | $1.37B | $1.31B | $1.23B | $1.86B | $1.19B | $1.10B | $1.01B | $1.70B | $1.64B | $1.90B | $1.35B | $1.54B | $1.41B | $1.38B | $1.29B | $1.35B | $1.07B | $995.03M |
| Low Forecast | $1.75B | $1.72B | $1.67B | $1.80B | $1.94B | $1.90B | $1.71B | $1.65B | $1.62B | $1.55B | $1.47B | $1.39B | $1.33B | $1.27B | $1.19B | $1.24B | $1.18B | $1.07B | $977.08M | $1.13B | $1.59B | $1.27B | $1.33B | $1.03B | $1.39B | $1.36B | $1.27B | $897.54M | $1.05B | $979.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.94% | 0.95% | 0.79% | 1.09% | 1.12% | 1.17% | 0.99% | 1.06% | 1.07% | 1.12% | 1.15% | 1.04% | 1.06% |
6 analysts predict LRCX's average Quarter EBITDA for Mar 24 to be $1.55B, with a high of $1.86B and a low of $1.24B. This is 46.98% upper than Lam Research's previous annual EBITDA (Dec 23) of $1.06B.
Lam Research Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 13 | 7 | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 6 | 7 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $954.27M | $887.40M | $802.54M | $814.01M | $1.47B | $1.43B | $1.21B | $1.02B | $1.19B | $1.18B | $1.14B | $1.07B | $869.23M | $823.45M |
| Avg Forecast | $1.70B | $1.66B | $1.43B | $1.58B | $1.77B | $1.74B | $1.60B | $1.53B | $1.50B | $1.40B | $1.30B | $1.20B | $1.12B | $1.06B | $993.24M | $1.25B | $932.90M | $806.43M | $664.31M | $1.14B | $1.31B | $1.27B | $959.75M | $1.04B | $1.12B | $1.08B | $994.79M | $930.35M | $751.38M | $681.16M |
| High Forecast | $1.73B | $1.68B | $1.45B | $1.60B | $1.80B | $1.77B | $1.63B | $1.55B | $1.52B | $1.43B | $1.32B | $1.21B | $1.13B | $1.06B | $1.01B | $1.51B | $965.93M | $819.62M | $675.18M | $1.37B | $1.34B | $1.53B | $967.60M | $1.24B | $1.13B | $1.09B | $1.00B | $1.12B | $757.53M | $686.74M |
| Low Forecast | $1.66B | $1.62B | $1.39B | $1.54B | $1.73B | $1.69B | $1.56B | $1.49B | $1.46B | $1.37B | $1.27B | $1.17B | $1.09B | $1.05B | $969.02M | $1.00B | $915.72M | $786.77M | $648.11M | $912.33M | $1.28B | $1.02B | $948.04M | $829.40M | $1.10B | $1.07B | $982.66M | $744.28M | $742.22M | $672.86M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.10% | 1.21% | 0.71% | 1.12% | 1.12% | 1.26% | 0.99% | 1.07% | 1.09% | 1.15% | 1.15% | 1.16% | 1.21% |
Lam Research's average Quarter net income forecast for Mar 24 is $1.25B, with a range of $1.00B to $1.51B. LRCX's average Quarter net income forecast represents a 31.46% increase compared to the company's last Quarter net income of $954.27M (Dec 23).
Lam Research SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 13 | 7 | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 6 | 7 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $228.84M | $207.02M | $199.83M | $193.50M | $233.80M | $205.62M | $210.00M | $217.41M | $236.13M | $222.19M | $217.53M | $203.70M | $218.90M | $189.75M |
| Avg Forecast | $315.99M | $311.75M | $301.88M | $324.45M | $349.84M | $344.20M | $308.89M | $298.65M | $292.06M | $279.73M | $265.05M | $250.75M | $240.17M | $228.75M | $215.68M | $266.92M | $209.61M | $193.12M | $176.60M | $242.65M | $287.79M | $239.95M | $237.63M | $220.59M | $249.07M | $243.87M | $227.38M | $176.93M | $188.39M | $175.37M |
| High Forecast | $319.96M | $315.68M | $305.68M | $328.53M | $354.24M | $348.53M | $312.78M | $302.41M | $295.73M | $283.25M | $268.39M | $253.90M | $243.19M | $231.63M | $218.39M | $320.30M | $211.87M | $195.55M | $178.82M | $291.18M | $291.41M | $287.94M | $239.13M | $264.71M | $250.64M | $245.40M | $228.81M | $212.32M | $189.57M | $176.47M |
| Low Forecast | $310.06M | $305.91M | $296.22M | $318.37M | $343.28M | $337.74M | $303.10M | $293.05M | $286.58M | $274.49M | $260.08M | $246.04M | $235.67M | $224.46M | $211.63M | $213.53M | $209.05M | $189.50M | $173.29M | $194.12M | $282.39M | $191.96M | $235.40M | $176.47M | $246.74M | $241.58M | $225.25M | $141.55M | $186.62M | $173.72M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.07% | 1.13% | 0.80% | 0.81% | 0.86% | 0.88% | 0.99% | 0.95% | 0.91% | 0.96% | 1.15% | 1.16% | 1.08% |
Lam Research's average Quarter SG&A projection for Mar 24 is $266.92M, based on 6 Wall Street analysts, with a range of $213.53M to $320.30M. The forecast indicates a 16.64% rise compared to LRCX last annual SG&A of $228.84M (Dec 23).
Lam Research EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 13 | 7 | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 6 | 7 | 14 | 7 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.25 | $6.69 | $5.99 | $6.03 | $10.80 | $10.42 | $8.76 | $7.34 | $8.50 | $8.32 | $8.02 | $7.51 | $6.04 | $5.67 |
| Avg Forecast | $12.96 | $12.64 | $10.90 | $12.03 | $13.52 | $13.25 | $12.21 | $11.66 | $11.42 | $10.72 | $9.94 | $9.12 | $8.52 | $8.05 | $7.58 | $7.30 | $7.12 | $6.15 | $5.07 | $6.52 | $10.03 | $9.57 | $7.32 | $7.52 | $8.51 | $8.23 | $7.59 | $6.62 | $5.73 | $5.20 |
| High Forecast | $13.17 | $12.85 | $11.08 | $12.23 | $13.74 | $13.46 | $12.41 | $11.85 | $11.60 | $10.89 | $10.10 | $9.27 | $8.66 | $8.10 | $7.70 | $7.42 | $7.37 | $6.25 | $5.15 | $6.63 | $10.19 | $9.73 | $7.38 | $7.58 | $8.58 | $8.29 | $7.65 | $6.67 | $5.78 | $5.24 |
| Low Forecast | $12.64 | $12.33 | $10.64 | $11.74 | $13.19 | $12.92 | $11.91 | $11.37 | $11.14 | $10.45 | $9.69 | $8.89 | $8.31 | $8.00 | $7.39 | $7.12 | $6.98 | $6.00 | $4.94 | $6.36 | $9.78 | $9.34 | $7.23 | $7.43 | $8.41 | $8.13 | $7.49 | $6.54 | $5.66 | $5.13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.09% | 1.18% | 0.92% | 1.08% | 1.09% | 1.20% | 0.98% | 1.00% | 1.01% | 1.06% | 1.13% | 1.05% | 1.09% |
According to 6 Wall Street analysts, Lam Research's projected average Quarter EPS for Mar 24 is $7.30, with a low estimate of $7.12 and a high estimate of $7.42. This represents a 0.66% increase compared to LRCX previous annual EPS of $7.25 (Dec 23).
Lam Research Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| IPGP | IPG Photonics | $65.54 | $146.00 | 122.76% | Buy |
| AEHR | Aehr Test Systems | $14.00 | $25.00 | 78.57% | Buy |
| KLIC | Kulicke and Soffa Industries | $39.77 | $65.00 | 63.44% | Hold |
| ACLS | Axcelis | $100.74 | $137.00 | 35.99% | Buy |
| ENTG | Entegris | $110.17 | $148.30 | 34.61% | Buy |
| TER | Teradyne | $126.10 | $153.18 | 21.48% | Buy |
| ASML | ASML | $795.60 | $905.67 | 13.83% | Buy |
| AMAT | Applied Materials | $180.24 | $201.30 | 11.68% | Buy |
| PLAB | Photronics | $22.88 | $25.50 | 11.45% | Buy |
| LRCX | Lam Research | $755.92 | $827.05 | 9.41% | Buy |
| KLAC | KLA | $728.06 | $590.28 | -18.92% | Buy |
LRCX Forecast FAQ
Is Lam Research a good buy?
Yes, according to 17 Wall Street analysts, Lam Research (LRCX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 58.82% of LRCX's total ratings.
What is LRCX's price target?
Lam Research (LRCX) average price target is $827.05 with a range of $543 to $1.13K, implying a 9.38% from its last price of $756.12. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Lam Research stock go up soon?
According to Wall Street analysts' prediction for LRCX stock, the company can go up by 9.38% (from the last price of $756.12 to the average price target of $827.05), up by 49.45% based on the highest stock price target, and down by -28.19% based on the lowest stock price target.
Can Lam Research stock reach $1.1K?
LRCX's highest twelve months analyst stock price target of $1.13K supports the claim that Lam Research can reach $1.1K in the near future.
What are Lam Research's analysts' financial forecasts?
Lam Research's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $20.9B (high $21.16B, low $20.51B), average EBITDA is $6.65B (high $6.73B, low $6.52B), average net income is $6.03B (high $6.13B, low $5.88B), average SG&A $1.18B (high $1.19B, low $1.16B), and average EPS is $46 (high $46.75, low $44.88). LRCX's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $23.4B (high $23.69B, low $22.96B), average EBITDA is $7.44B (high $7.54B, low $7.31B), average net income is $6.52B (high $6.62B, low $6.36B), average SG&A $1.32B (high $1.34B, low $1.3B), and average EPS is $49.7 (high $50.51, low $48.49).
Did the LRCX's actual financial results beat the analysts' financial forecasts?
Based on Lam Research's last annual report (Jun 2023), the company's revenue was $17.43B, beating the average analysts forecast of $16.97B by 2.71%. Apple's EBITDA was $5.6B, missing the average prediction of $5.62B by -0.27%. The company's net income was $4.51B, beating the average estimation of $4.39B by 2.67%. Apple's SG&A was $832.75M, missing the average forecast of $946.99M by -12.06%. Lastly, the company's EPS was $42.13, beating the average prediction of $31.19 by 35.07%. In terms of the last quarterly report (Dec 2023), Lam Research's revenue was $3.76B, beating the average analysts' forecast of $3.71B by 1.17%. The company's EBITDA was $1.06B, missing the average prediction of $1.18B by -10.55%. Lam Research's net income was $954.27M, beating the average estimation of $932.9M by 2.29%. The company's SG&A was $228.84M, beating the average forecast of $209.61M by 9.18%. Lastly, the company's EPS was $7.25, beating the average prediction of $7.12 by 1.89%